Daan Gene Co., Ltd. (SHE:002030)

Daan Gene Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Jan 1, 2024	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	-	506.29	872.09	999.37	2,594	2,179
Short-Term Investments	-	388.19	858.76	1,310	485.37	-
Trading Asset Securities	-	593.89	63	90.08	480.9	380.01
Cash & Short-Term Investments	1,102	1,488	1,794	2,400	3,561	2,559
Cash Growth	-15.22%	-17.03%	-25.25%	-32.61%	39.15%	45.53%
Accounts Receivable	-	819.23	1,318	2,170	4,247	2,352
Other Receivables	-	26.34	33.62	50	52.76	56.46
Receivables	-	914.08	1,461	2,353	4,445	2,525
Inventory	-	147.58	198.21	239.52	369.6	493.72
Other Current Assets	-	293.55	328.66	318.19	393.98	407.6
Total Current Assets	-	2,844	3,782	5,310	8,769	5,985
Property, Plant & Equipment	-	1,500	1,790	1,903	1,767	863.06
Long-Term Investments	-	2,899	2,537	2,517	3,070	2,703
Other Intangible Assets	-	418.39	572.72	279.7	204.12	115.03
Long-Term Accounts Receivable	-	99.87	87.47	35.91	72.05	16.62
Long-Term Deferred Tax Assets	-	344.36	358.39	228.9	199.34	112.69
Long-Term Deferred Charges	-	291.23	397.58	670.48	574.92	331.52
Other Long-Term Assets	-	87.54	34.39	57.21	99.95	209.08
Total Assets	-	8,511	9,577	11,018	14,757	10,336

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Jan 1, 2024	Jan 1, 2023	Jan 1, 2022
Accounts Payable	-	259.68	357.87	425.44	737.07	553.01
Accrued Expenses	-	485.7	569.74	760.13	1,559	985.63
Short-Term Debt	-	103.79	143.53	330.8	117.76	282.59
Current Portion of Leases	-	3.32	6.95	13.21	42.66	45.32
Current Income Taxes Payable	-	28.03	28.12	29.69	302	383.47
Current Unearned Revenue	-	35.29	66.23	34.23	69.34	152.45
Other Current Liabilities	-	91.57	121.3	127.58	140.9	118.58
Total Current Liabilities	-	1,007	1,294	1,721	2,969	2,521
Long-Term Leases	-	3.37	13.46	21.81	67.38	76.15
Long-Term Unearned Revenue	-	44.94	58.53	32.69	27.27	30.14
Long-Term Deferred Tax Liabilities	-	63.88	61.24	79.85	47.97	46.97
Other Long-Term Liabilities	-	26.15	6.93	5.41	29.8	2.17
Total Liabilities	-	1,146	1,434	1,861	3,141	2,676

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Jan 1, 2024	Jan 1, 2023	Jan 1, 2022
Common Stock	-	1,403	1,403	1,403	1,403	1,403
Additional Paid-In Capital	-	601.69	600.97	651.54	719.99	621.38
Retained Earnings	-	5,139	5,883	6,829	9,181	5,326
Comprehensive Income & Other	-	-5.84	-7.41	-3.92	-2.85	0.5
Total Common Equity	7,040	7,138	7,880	8,880	11,301	7,351
Minority Interest	-	226.92	263.07	276.83	314.79	308.63
Shareholders' Equity	7,267	7,365	8,143	9,157	11,616	7,660
Total Liabilities & Equity	-	8,511	9,577	11,018	14,757	10,336

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Jan 1, 2024	Jan 1, 2023	Jan 1, 2022
Total Debt	123.29	110.48	163.94	365.83	227.8	404.06
Net Cash (Debt)	979.1	1,378	1,630	2,034	3,333	2,155
Net Cash Growth	-18.50%	-15.46%	-19.86%	-38.98%	54.66%	60.03%
Net Cash Per Share	0.71	0.98	1.16	1.36	2.37	1.54
Filing Date Shares Outstanding	1,273	1,403	1,403	1,403	1,403	1,403
Total Common Shares Outstanding	1,273	1,403	1,403	1,403	1,403	1,403
Working Capital	-	1,836	2,488	3,589	5,800	3,464
Book Value Per Share	5.02	5.09	5.61	6.33	8.05	5.24
Tangible Book Value	6,644	6,719	7,307	8,601	11,097	7,236
Tangible Book Value Per Share	4.73	4.79	5.21	6.13	7.91	5.16
Buildings	-	1,139	807.22	766.64	618.81	293.09
Machinery	-	1,032	1,141	1,155	1,017	591.94
Construction In Progress	-	311.71	776.1	727.35	576.63	210.65

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 11, 2026

Data Sources Report a data error